Background: Many literature reviews report vitamin E supplementation as a benefit chemopreventive and adjuvant therapy in breast and prostate cancers. We investigated in the present work, alpha-tocopherol (α-T) expression (the current active form of vitamin E) from tissues of Congolese patients neither smokers nor alcohol drinkers and without intake antioxidant vitamins supplement. Methods: α-T was analysed in one normal placenta of nine weeks of gestation and in nineteen cancerous tissues, including seven breast cancers, six prostate cancers, and six gestational choriocarcinomas. The study was performed by immunohistochemistry method after diagnosis confirmation by histological analysis. Results: α-T staining in membrane cells and collagen fibers presented a moderate expression in healthy sections of tissues (positive control), but the labelling was strong in breast, prostate adenocarcinomas, and in choriocarcinomas. Conclusion: Tumors immunohistochemistry of α-tocopherol in breast, prostate cancers and in choriocarcinoma show elevated immunostaining suggesting a probable oncogenic effect of the micronutrient.
References
[1]
Poljsak, B. and Milisav, I. (2018) The Role of Antioxydant in Cancer, Friends or Foes? Current Pharmaceutical Design, 24, 5234-5244. https://doi.org/10.2174/1381612825666190123112647
[2]
Greenlee, H., Kwan, M.L., Ergas, I.J., et al. (2014) Changes in Vitamin and Mineral Supplement Use after Breast Cancer Diagnosis in the Pathways Study: A Prospective Cohort Study. BMC Cancer, 14, Article No. 382. https://doi.org/10.1186/1471-2407-14-382
[3]
Brigelius-Flohé, R., Kelly, F.J., Salonen, J.T., et al. (2002) The European Perspective on Vitamin E: Current Knowledge and Future Research. The American Journal of Clinical Nutrition, 76, 703-716. https://doi.org/10.1093/ajcn/76.4.703
[4]
Herrera, E. and Barbas, C.J. (2001) Vitamin E: Action, Metabolism and Perspectives. Journal of Physiology and Biochemistry, 57, 43-56. https://doi.org/10.1007/BF03179812
[5]
Arita, M., Sato, Y., Miyata, A., et al. (1995) Human α-Tocopherol Transfer Protein: cDNA Cloning, Expression and Chromosomal Localization. Biochemical Journal, 306, 437-443. https://doi.org/10.1042/bj3060437
[6]
Jiang, Q. (2017) Natural Forms of Vitamin E as Effective Agents for Cancer Prevention and Therapy. Advances in Nutrition, 8, 850-867. https://doi.org/10.3945/an.117.016329
[7]
Smolarek, A.K., So, J.Y., Burgess, B., Kong, A.-N.T., et al. (2012) Dietary Administration of δ and γ Tocopherol Inhibits Tumorigenesis in the Animal Model of Estrogen Receptor-Positive, but Not HER-2 Breast Cancer. Cancer Prevention Research, 5, 1310-1320. https://doi.org/10.1158/1940-6207.CAPR-12-0263
[8]
Hu, X.-X., Fu, L., Li, Y., et al. (2015) The Cardioprotective Effect of Vitamin E (Alpha-Tocopherol) Is Strongly Related to Age and Gender in Mice. PLoS ONE, 10, e0137405. https://doi.org/10.1371/journal.pone.0137405
[9]
Smolarek, A.K. and Suh, N. (2011) Chemopreventive Activity of Vitamin E in Breast Cancer: A Focus on γ- and δ-Tocopherol. Nutrients, 3, 962-986. https://doi.org/10.3390/nu3110962
[10]
Erbas, H., Türksever, A., Aydogdu, N., et al. (2015) Asymmetric Dimethylarginine in Experimental Breast Cancer; Action of Vitamin C and E. Journal of Pakistan Medical Association, 65, 829-833.
[11]
Sondé Malanda, J., Nkoua Mbon, J.B., Tozoula Bambara, A., et al. (2013) Twelve Years of Working of Brazzaville Cancer Registry. Bulletin du Cancer, 100, 135-139. https://doi.org/10.1684/bdc.2013.1701
[12]
Barta, J.A., Powell, C.A. and Wisnivesky, J.P. (2019) Global Epidemiology of Lung Cancer. Annals of Global Health, 85, 8. https://doi.org/10.5334/aogh.2419
[13]
Bashir, M.N. (2015) Epidemiology of Prostate Cancer. Asian Pacific Journal of Cancer Prevention, 16, 5137-5141. https://doi.org/10.7314/APJCP.2015.16.13.5137
[14]
Vivarelli, F., Canistro, D., Cirillo, S., et al. (2019) Co-Carcinogenic Effects of Vitamin E in Prostate. Scientific Reports, 9, Article No. 11636. https://doi.org/10.1038/s41598-019-48213-1
[15]
Njoroge, R.N., Unno, K., Zhao, J.C., et al. (2017) Organoids Model Distinct Vitamin E Effects at Different Stages of Prostate Cancer Evolution. Scientific Reports, 7, Article No. 16285. https://doi.org/10.1038/s41598-017-16459-2
[16]
Harvie, M. (2014) Nutrtional Supplements and Cancer: Potential Benefits and Proven Harms. American Society of Clinical Oncology Educational Book, 34, e478-e486. https://doi.org/10.14694/EdBook_AM.2014.34.e478
[17]
Poaty, H., Aba Gandzion, C., Soubeyran, I., et al. (2017) The Identification of Lynch Syndrome in Congolese Colorectal Cancer Patients. Bulletin du Cancer, 104, 831-839. https://doi.org/10.1016/j.bulcan.2017.08.005
[18]
Nagamma, T., Baxi, J. and Singh, P.P. (2014) Status of Oxidative Stress and Antioxidant Levels in Smokers with Breast Cancer from Wester Nepal. Asian Pacific Journal of Cancer Prevention, 15, 9467-9470. https://doi.org/10.7314/APJCP.2014.15.21.9467
[19]
Wang, X. and Quinn, P.J. (1999) Vitamin E and Its Function in Membranes. Progress in Lipid Research, 38, 309-336. https://doi.org/10.1016/S0163-7827(99)00008-9
[20]
Covenas, R., Mangas, A., Bodet, D., et al. (2011) Frontiers in Vitamin Research: New Antibodies, New Data. The Scientific World Journal, 11, Article ID: 586180. https://doi.org/10.1100/tsw.2011.115
[21]
Lee, Y.K., Jung, W.H. and Koo, J.S. (2015) Adipocytes Can Induce Epithelial-Mesenchymal Transition in Breast Cancer Cells. Breast Cancer Research and Treatment, 153, 323-335. https://doi.org/10.1007/s10549-015-3550-9
[22]
Ramamoorthy, V., Rubens, M., Saxena, A. and Shehadeh, N. (2015) Selenium and Vitamin E for Prostate Cancer—Justifications for the SELECT Study. Asian Pacific Journal of Cancer Prevention, 16, 2619-2627. https://doi.org/10.7314/APJCP.2015.16.7.2619
[23]
Nechuta, S., Lu, W., Chen, Z., et al. (2011) Vitamin Supplement Use during Breast Cancer Treatment and Survival: A Prospective Cohort Study. Cancer Epidemiology, Biomarkers & Prevention, 20, 262-271. https://doi.org/10.1158/1055-9965.EPI-10-1072
[24]
Hu, F., Wu, Z., Li, G., et al. (2015) The Plasma Level of Retinol, Vitamins A, C and α-Tocopherol Could Reduce Breast Cancer Risk? A Meta-Analysis and Meta-Regression. Journal of Cancer Research and Clinical Oncology, 141, 601-614. https://doi.org/10.1007/s00432-014-1852-7
[25]
Tsavachidou, D., McDonnell, T.J., Wen, S., et al. (2008) Selenium and Vitamin E: Cell Type- and Intervention-Specific Tissue Effects in Prostate Cancer. Journal of the National Cancer Institute, 101, 306-320. https://doi.org/10.1093/jnci/djn512
[26]
Heinonen, O.P., Albanes, D., Virtamo, J., et al. (1998) Prostate Cancer and Supplementation with Alpha-Tocopherol and Beta-Carotene: Incidence and Mortality in Controlled Trial. Journal of the National Cancer Institute, 90, 440-446. https://doi.org/10.1093/jnci/90.6.440
[27]
Weinstein, S.J., Wright, M.E., Lawson, K.A., et al. (2007) Serum and Dietary Vitamin E in Relation to Prostate Cancer Risk. Cancer Epidemiology, Biomarkers & Prevention, 16, 1253-1259. https://doi.org/10.1158/1055-9965.EPI-06-1084
[28]
Waniek, S., Di Giuseppe, R., et al. (2018) Vitamin E (α- and γ-Tocopherol) Levels in the Community: Distribution, Clinical and Biochemical Correlates, and Association with Dietary Patterns. Nutrients, 10, 3. https://doi.org/10.3390/nu10010003
[29]
Aris, A., Leblanc, S., Ouellet, A. and Moutquin, J.-M. (2008) Detrimental Effect of High Levels of Antioxidant Vitamins C and E on Placental Function: Consideration for the Vitamins in Preeclampsia (VIP) Trial. Journal of Obstetrics and Gynaecology Research, 34, 504-511. https://doi.org/10.1111/j.1447-0756.2008.00722.x
[30]
Etzl, R.P., Vrekoussis, T., Kuhn, C., et al. (2012) Oxidative Stress Stimulates Alpha-Tocophérol Transfer Protein in Human Trophoblast Tumor Cells BeWo. Journal of Perinatal Medicine, 40, 373-378. https://doi.org/10.1515/jpm-2011-0307
[31]
Konig, J., Besoke, F., Stuetz, W., et al. (2016) Quantification of Age-Related Changes of α-Tocopherol in Lysosomal Membranes in Murine Tissues and Human Fibroblasts. Biofactors, 42, 307-315.
[32]
Diao, Q.X., Zhang, J.Z., Zhao, T., et al. (2016) Vitamin E Promotes Breast Cancer Cell Proliferation by Reducing ROS Production and p53 Expression. European Review for Medical and Pharmacological Sciences, 20, 2710-2717.
[33]
Rock, C.L., Doyle, C., Demark-Wahnefried, W., et al. (2012) Nutrition and Physical Activity Guidelines for Cancer Survivors. CA: A Cancer Journal for Clinicians, 62, 242-274. https://doi.org/10.3322/caac.21142
[34]
Ferrini, K., Ghelfi, F. and Mannucci, R. (2015) Lifestyle, Nutrition and Breast Cancer: Facts and Presumptions for Consideration. Ecancer Medical Science, 9, 557 https://doi.org/10.3332/ecancer.2015.557
